Clinical Trial Update: Trial of Citalopram for the Prevention of Depression [Phase 3]

View source ↗

Summary

Phase 3 trial assessing whether citalopram can prevent depression in individuals with HIV infection or Hepatitis C; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C
• Major Depressive Disorder

Drugs mentioned

• Citalopram (Citalopram hydrobromide)

Snippet

Sponsor: Marina Klein | Conditions: Depression, HIV Infections | Phase 3 | Status: COMPLETED